loading animation for AJAX calls
Items per page:   25 | 50 | 75 | 100

203 Reports in Biotechnology

Cancer Cell Analysis, Instruments, Consumables and Reagents

Published - Jan 2019 | Analyst - Sathya Durga| Code - BIO177A

The global market for cancer cell analysis should reach $10.8 billion by 2023 from $7.4 billion in 2018 at a compound annual growth rate (CAGR) of 7.8% for the period of 2018-2023.

Cell Separation and Characterization in Solid Tumors: Global Mark...

Published - Jan 2019 | Analyst - Anuj Pathak| Code - BIO167A

The global market for cell separation and characterization in solid tumors should grow from $1.8 billion in 2018 to reach $3.3 billion by 2023 at a compound annual growth rate (CAGR) of 12.5% for the period of 2018-2023.

Bioprocess Optimization and Digital Bio-manufacturing: Global Mar...

Published - Jan 2019 | Analyst - Kamna Jhamb| Code - BIO170A

The global market for bioprocess optimization and digital biomanufacturing will grow from nearly $26.5 billion in 2018 to nearly $40.5 billion by 2023 with a compound annual growth rate (CAGR) of 8.9% for the period of 2018-2023.

Biomarker Deals: Terms, Value and Trends, 2008-2018

Published - Jan 2019 | Analyst - Marianna Tcherpakov| Code - BIO169A

Over the last decade, biomarker research has become one of the essential aspects not only of the in vitro diagnostics industry but an important component of the drug discovery and development process. Moreover, with the growing trend in personalized medicine and companion diagnostics, the use of biomarkers is becoming obligatory in management of certain diseases, such as cancer drug regimen.

Chromatography in Pharmaceuticals and Biotechnology: Global Marke...

Published - Dec 2018 | Analyst - Kamna Jhamb| Code - BIO163A

The global market for chromatography instruments and reagents should grow from $9.8 billion in 2018 to $14.0 billion in 2023 at a compound annual growth rate (CAGR) of 7.3% from 2018 to 2023.

Cell-based Assays: Technologies and Global Markets

Published - Dec 2018 | Analyst - Sathya Durga| Code - BIO080D

The global market for cell-based assays should grow from $20.1 billion in 2018 to $32.7 billion by 2023 at a compound annual growth rate (CAGR) of 10.2% from 2018 through 2023.

High Content Screening/Imaging: Technologies and Global Markets

Published - Nov 2018 | Analyst - Anuj Pathak| Code - BIO166A

The global market for high content screening/imaging should grow from $915.0 million in 2018 to reach $1.7 billion by 2023 at a compound annual growth rate (CAGR) of 13.1% for the period of 2018-2023.

Bioinformatics: Technologies and Global Markets

Published - Nov 2018 | Analyst - Vijay Laxmi| Code - BIO051D

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

Proteomics: Technologies and Global Markets

Published - Oct 2018 | Analyst - Bhavna Joshi| Code - BIO034E

The global market for proteomics should grow from $7.9 billion in 2017 to $16.8 billion by 2022 at a compound annual growth rate (CAGR) of 16.2% for the period of 2017-2022.

Protein Analysis: Subfocus on Oncoproteomics

Published - Oct 2018 | Analyst - Anuj Pathak| Code - BIO168A

The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.

Genetic Modification Therapies Clinical Applications: Gene Thera...

Published - Sep 2018 | Analyst - John Bergin| Code - BIO159A

The global market for genetic modification therapies should grow from $2.3 billion in 2018 to reach $17.4 billion by 2023, growing at a compound annual growth rate (CAGR) of 49.9% during the forecast period of 2018-2023.

Biomarkers: Technologies and Global Markets

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO061E

The global market for biomarkers should grow from $78.9 billion in 2018 to $136.5 billion by 2023 at a compound annual growth rate (CAGR) of 11.6% from 2018 through 2023.

Next Generation Sequencing for Non-invasive Prenatal Testing: Glo...

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO173A

The global market for non-invasive prenatal testing (NIPT) should grow from $1.9 billion in 2018 to reach $3.1 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2018-2023.

Global Markets for Enzymes in Industrial Applications

Published - Sep 2018 | Analyst - BCC Research Staff| Code - BIO030K

The global industrial enzymes market should reach $7.0 billion by 2023 from $5.5 billion in 2018 at a compound annual growth rate (CAGR) of 4.9% for the period 2018-2023.

Switching to CRISPR–Cas Systems from Uncultivated Microbes

Published - Sep 2018 | Analyst - Mike (Ke Ke) Fan| Code - BIO172A

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology is currently the biggest discovery in life science. As a precise gene editing tool, it has been widely used in many areas with a great potential to treat human diseases. While some CRISPR-based therapeutic studies are moving to clinical trials, CRISPR's therapeutic promise was brought into question when some issues were found that could become major obstacles in moving the great genome editing tools to the clinic.While many groups are actively resolving these obstacles, the significant challenges to minimize the immunological risks and avoid potential tumorgenicity have received more attention as big concerns for CRISPR-Cas therapeutics advancing toward the clinic. We believe it is timely to summarize and analyze the emerging immunological risk and potential tumorgenicity with the CRISPR-Cas systems, to predict how this exciting genome editing market will affect other related segments of the entire life science market in the next few years. We also hope our opinion could serve as a "crowd crystal" on those discussions in response to the issues, and bring a better market environment for the technology to be sharpened and advanced into clinical applications.

Current Research & Developments Status of Chimeric Antigen Recept...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO162A

The global market for Chimeric Antigen Receptor (CAR) T-cell therapies will grow from nearly $467.0 million in 2018 to $2.9 billion by 2023 at a compound annual growth rate (CAGR) of 44.1% for the period of 2018-2023.

Adoptive Transfer of Autologous Lymphocytes Targeting Somatically...

Published - Aug 2018 | Analyst - Paul Taylor| Code - BIO171A

Adoptive Cell Therapies (ACTs) and the infusion of autologous or redirected tumor-specific T-cells have the potential to drastically impact the treatment of a variety of cancers, especially common epithelial cancers. This report summarizes the current state of clinical research and trials, explains the impact of ACTs on the treatment of several metastasized malignancies, and also raises important concerns about the scalability and compatibility of TILs.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnosti...

Published - Aug 2018 | Analyst - Todd Graham| Code - BIO157A

The global market for polymerase chain reaction (PCR) in point of care (POC) diagnostics totaled $2.9 billion in 2018 and is estimated to reach $4.8 billion by 2023, growing at a compound annual growth rate (CAGR) of 10.6% for the period of 2018-2023.

Microbial Products: Technologies, Applications and Global Markets

Published - Aug 2018 | Analyst - Andrew McWilliams| Code - BIO086D

The global microbes and microbial products market should reach $302.4 billion by 2023 from $186.3 billion in 2018 at a compound annual growth rate (CAGR) of 10.2% for the period 2018-2023.

Immunohistochemistry (IHC): Global Markets to 2022

Published - Aug 2018 | Analyst - Vijay Laxmi| Code - BIO161A

The global immunohistochemistry market totaled $1.6 billion in 2017 and is estimated to reach $2.3 billion by 2022, growing at a compound annual growth rate (CAGR) of 7.8% for the period of 2017-2022.

Global Markets for Media, Sera and Reagents in Biotechnology

Published - Aug 2018 | Analyst - BCC Research Staff| Code - BIO014K

The global market for media, sera and reagents in biotechnology should reach $5.5 billion by 2023 from $4.1 billion in 2018 at a compound annual growth rate (CAGR) of 6.0% for the period 2018-2023.

Synthetic Biology: Global Markets

Published - Jul 2018 | Analyst - John Bergin| Code - BIO066E

The global market for synthetic biology will grow from nearly $4.4 billion in 2017 to $13.9 billion by 2022, with a compound annual growth rate (CAGR) of 26.0% for the period of 2017-2022.

Cardiac Biomarkers: Technologies and Global Markets

Published - Jul 2018 | Analyst - Paul Taylor| Code - BIO128C

The global market for cardiac biomarker will grow from $6.3 billion in 2017 to $9.9 billion by 2022, at a compound annual growth rate (CAGR) of 9.5% for the period of 2017-2022

Digital Polymerase Chain Reaction (PCR) Technology: Global Market...

Published - Jun 2018 | Analyst - Todd Graham| Code - BIO137B

The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.

Exosome Diagnostics and Therapeutics: Global Markets

Published - Jun 2018 | Analyst - Marianna Tcherpakov| Code - BIO149B

The global market for exosome industry should reach $180.0 million by 2023 from $25 million in 2018 at a compound annual growth rate (CAGR) of 48.4% for the period 2018-2023.

16 Upcoming Reports in Biotechnology

Flow Cytometry: Products, Technologies and Global Markets

Target Date - Jan 2019| Author - Honey Dave| Code - BIO085D| Price - $5,500

Report Includes

  • An industry analysis of the products, technologies and applications of flow cytometry within the industry
  • Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Segmentation of the global flow cytometry market by products and services, technology types, applications, end users and geographical regions
  • A look at the regulatory environment and growth driving factors that affect the global market
  • Separate chapter on number of U.S. patents and patent applications with emphasis on new developments
  • Detailed profiling of leading companies in flow cytometry industry

Notify Me

Protein Expression: Global Markets Through 2022

Target Date - Jan 2019| Author - Sangeeta Rai| Code - BIO165A| Price - $5,500

Report Includes

  • An overview of the global markets for protein expressions
  • Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion on perfusion approaches and supporting practices such as continuous bio manufacturing, and digital and model based controls
  • Overview of post-translational modification such as glycosylation
  • Detailed analysis of the cloning technologies, production of recombinant proteins and problems associated with protein production
  • Profiles of major players in the industry, including Thermo Fisher Scientific Inc., Merck KGaA, Promega Corporation, Agilent Technologies, and GenScript

Notify Me

 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM